Cetuximab [cetuximab]

topical
186
Terms

Erbitux

 

C225
Erbitux
IMC C225
IMC-C225
MAb C225

Persistent link   https://www.medvik.cz/link/D000068818
Definition

A chimeric monoclonal antibody that functions as an ANTINEOPLASTIC AGENT through its binding to the EPIDERMAL GROWTH FACTOR RECEPTOR, where it prevents the binding and signaling action of cell growth and survival factors.

DUI
D000068818 MeSH Browser
CUI
M0422675
History note
2016 (2000)
Public note
2016; CETUXIMAB was indexed under ANTIBODIES, MONOCLONAL 2000-2013; and under ANTIBODIES, MONOCLONAL, HUMANIZED 2013-2015

Allowable subheadings

AD
administration & dosage 37
AE
adverse effects 23
AN
analysis
BI
biosynthesis
BL
blood
CF
cerebrospinal fluid
CH
chemistry 2
CL
classification
DE
drug effects 1
EC
economics 2
GE
genetics
HI
history
IM
immunology 1
IP
isolation & purification
ME
metabolism 1
PK
pharmacokinetics 1
PD
pharmacology 41
PH
physiology
PO
poisoning
RE
radiation effects
TU
therapeutic use 103
TO
toxicity 1
UL
ultrastructure
UR
urine

D Chemicals and Drugs
D12 Amino Acids, Peptides, and Proteins 16
D12.776 Proteins 2 587
D12.776.124 Blood Proteins 911
D12.776.124.486 Immunoproteins 14
D12.776.124.486.485 Immunoglobulins 1 494
D12.776.124.486.485.114 Antibodies 1 818
D12.776.124.486.485.114.224 Antibodies, Monoclonal 4 704
D12.776.124.486.485.114.224.060 Antibodies, Monoclonal, Humanized 2 960
D12.776.124.486.485.114.224.060.125 Abciximab 14
D12.776.124.486.485.114.224.060.250 Adalimumab 357
D12.776.124.486.485.114.224.060.313 Alemtuzumab 125
D12.776.124.486.485.114.224.060.344 Basiliximab 2
D12.776.124.486.485.114.224.060.375 Bevacizumab 456
D12.776.124.486.485.114.224.060.438 Brentuximab Vedotin 45
D12.776.124.486.485.114.224.060.500 Certolizumab Pegol 49
D12.776.124.486.485.114.224.060.750 Cetuximab 186
D12.776.124.486.485.114.224.060.766 Daclizumab 6
D12.776.124.486.485.114.224.060.782 Denosumab 158
D12.776.124.486.485.114.224.060.790 Gemtuzumab 19
D12.776.124.486.485.114.224.060.794 Inotuzumab Ozogamicin 12
D12.776.124.486.485.114.224.060.798 Ipilimumab 267
D12.776.124.486.485.114.224.060.813 Natalizumab 158
D12.776.124.486.485.114.224.060.829 Nivolumab 461
D12.776.124.486.485.114.224.060.844 Omalizumab 115
D12.776.124.486.485.114.224.060.860 Palivizumab 13
D12.776.124.486.485.114.224.060.864 Panitumumab 62
D12.776.124.486.485.114.224.060.866 Ramucirumab 1
D12.776.124.486.485.114.224.060.868 Ranibizumab 63
D12.776.124.486.485.114.224.060.875 Trastuzumab 278
D12.776.124.486.485.114.224.060.937 Ustekinumab 125
D12.776.124.790 Serum Globulins 61
D12.776.124.790.651 Immunoglobulins 1 494
D12.776.124.790.651.114 Antibodies 1 818
D12.776.124.790.651.114.224 Antibodies, Monoclonal 4 704
D12.776.124.790.651.114.224.060 Antibodies, Monoclonal, Humanized 2 960
D12.776.124.790.651.114.224.060.125 Abciximab 14
D12.776.124.790.651.114.224.060.250 Adalimumab 357
D12.776.124.790.651.114.224.060.375 Alemtuzumab 125
D12.776.124.790.651.114.224.060.407 Basiliximab 2
D12.776.124.790.651.114.224.060.438 Bevacizumab 456
D12.776.124.790.651.114.224.060.469 Brentuximab Vedotin 45
D12.776.124.790.651.114.224.060.500 Certolizumab Pegol 49
D12.776.124.790.651.114.224.060.750 Cetuximab 186
D12.776.124.790.651.114.224.060.766 Daclizumab 6
D12.776.124.790.651.114.224.060.782 Denosumab 158
D12.776.124.790.651.114.224.060.790 Gemtuzumab 19
D12.776.124.790.651.114.224.060.794 Inotuzumab Ozogamicin 12
D12.776.124.790.651.114.224.060.798 Ipilimumab 267
D12.776.124.790.651.114.224.060.813 Natalizumab 158
D12.776.124.790.651.114.224.060.829 Nivolumab 461
D12.776.124.790.651.114.224.060.844 Omalizumab 115
D12.776.124.790.651.114.224.060.860 Palivizumab 13
D12.776.124.790.651.114.224.060.864 Panitumumab 62
D12.776.124.790.651.114.224.060.866 Ramucirumab 1
D12.776.124.790.651.114.224.060.868 Ranibizumab 63
D12.776.124.790.651.114.224.060.875 Trastuzumab 278
D12.776.124.790.651.114.224.060.937 Ustekinumab 125
D12.776.377 Globulins 68
D12.776.377.715 Serum Globulins 61
D12.776.377.715.548 Immunoglobulins 1 494
D12.776.377.715.548.114 Antibodies 1 818
D12.776.377.715.548.114.224 Antibodies, Monoclonal 4 704
D12.776.377.715.548.114.224.200 Antibodies, Monoclonal, Humanized 2 960
D12.776.377.715.548.114.224.200.125 Abciximab 14
D12.776.377.715.548.114.224.200.250 Adalimumab 357
D12.776.377.715.548.114.224.200.375 Alemtuzumab 125
D12.776.377.715.548.114.224.200.407 Basiliximab 2
D12.776.377.715.548.114.224.200.438 Bevacizumab 456
D12.776.377.715.548.114.224.200.469 Brentuximab Vedotin 45
D12.776.377.715.548.114.224.200.500 Certolizumab Pegol 49
D12.776.377.715.548.114.224.200.750 Cetuximab 186
D12.776.377.715.548.114.224.200.766 Daclizumab 6
D12.776.377.715.548.114.224.200.782 Denosumab 158
D12.776.377.715.548.114.224.200.790 Gemtuzumab 19
D12.776.377.715.548.114.224.200.794 Inotuzumab Ozogamicin 12
D12.776.377.715.548.114.224.200.798 Ipilimumab 267
D12.776.377.715.548.114.224.200.813 Natalizumab 158
D12.776.377.715.548.114.224.200.829 Nivolumab 461
D12.776.377.715.548.114.224.200.844 Omalizumab 115
D12.776.377.715.548.114.224.200.860 Palivizumab 13
D12.776.377.715.548.114.224.200.864 Panitumumab 62
D12.776.377.715.548.114.224.200.866 Ramucirumab 1
D12.776.377.715.548.114.224.200.868 Ranibizumab 63
D12.776.377.715.548.114.224.200.875 Trastuzumab 278
D12.776.377.715.548.114.224.200.937 Ustekinumab 125

64Cu-DOTA-cetuximab Chemical MeSH Browser

Add